In a recent interview with Culture Magazine, he said:
“I have never used it. First of all, I am still interested, but as I did research and we had official supply of cannabis, obviously if we had used it for non-scientific reasons, if people had come to know about it that would have stopped our work. Basically, neither I nor my students were interested.”
Over the next few years, his group would become the first to isolate and synthesize cannabidiol, or CBD, now revered for its potential medical applications, as well as tetrahydrocannabinol, or THC, the psychoactive compound in marijuana that makes users feel high.
Mechoulam’s work also opened the door for more recent developments in the field of marijuana medicine.
Studies have shown that cannabinoids have promise in the treatment of ailments including cancer, epilepsy, chronic pain, anxiety and even some psychotic symptoms.